IVIG in Patients With VGKC Ab Associated Autoimmune Epilepsy
Status:
Terminated
Trial end date:
2018-12-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether intravenous immunoglobulin (IVIG) treatment
reduces significantly the number of epileptic seizures in cases of autoimmune epileptic
seizures.